<DOC>
	<DOCNO>NCT02131051</DOCNO>
	<brief_summary>This comparative , open label , parallel group , non interventional study demonstrate effectiveness tolerability Ectoin Allergy Nasal Spray Eye drop . In addition effectiveness safety shall compare Azelastine contain nasal Sprays Eye drop . The patient apply EctoinÂ® Rhinitis Nasal Spray / Eye drop take Azelastine nasal spray eye drop accord instruction use . The observation take place period 7 day . Response treatment record day 7 physician daily patient dairy .</brief_summary>
	<brief_title>Application Ectoine Containing Nasal Spray Eye Drops Patients With Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Azelastine</mesh_term>
	<criteria>male female patient age 1870 year Patients proven allergy acute symptom nose eye treat Ectoin Allergy Nasal Spray Ectoin Allergy Eye Drops Azelastine Nasal Spray Azelastine Eye Drops observational period pregnancy nurse woman , drug addict person unable give consent study participation , patient intolerance ingredient study treatment , previous eye nose surgery , concomitant treatment antiallergic drug , disease might influence output study accord physician ' judgment . contra indication accord label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>ectoine</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>bitop</keyword>
</DOC>